Phase II Pethema trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics

查看全文 作　　者：Rosinol L; Oriol A; Mateos MV; 出　　处：《J Clin Oncol》索引2007年第25卷,共0页